Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07829471) titled 'Impact of Routine Electronic Patient-Reported Outcome (ePRO)Symptom Monitoring During Neoadjuvant Therapy in Patients withPancreatic Adenocarcinoma on Patient Experience and ClinicalOutcomes: A Prospective Pre-Post Implementation Study' on Sept. 17.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).
Primary Sponsor: M.D. Anderson Cancer Center
Condition:
ePRO
Symptom Monitoring
Neoadjuvant Therapy
Pancreatic Adenocarcinoma
Clinical Outcomes
Intervention:
Other: Standard of Care
Recruitm...